Published in J Med Chem on October 21, 1999
(E)-Methyl N'-(4-hydroxy-benzyl-idene)hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2008) 1.49
(E)-Methyl N'-[1-(4-methoxy-phen-yl)ethyl-idene]hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2008) 1.41
Ethyl N'-[(E)-4-hydroxy-benzyl-idene]hydrazinecarboxyl-ate at 123 K. Acta Crystallogr Sect E Struct Rep Online (2008) 1.19
(E)-Ethyl N'-(4-bromo-benzyl-idene)hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2008) 0.97
Rapid multistep synthesis of 1,2,4-oxadiazoles in a single continuous microreactor sequence. J Org Chem (2008) 0.89
Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs. Bioorg Med Chem (2009) 0.85
Methyl 2-[(E)-3-hydr-oxy-4-methoxy-benzyl-idene]hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
(E)-Methyl N'-(2,4,5-trimeth-oxy-benzyl-idene)hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
(E)-Ethyl N'-[1-(4-methoxy-phen-yl)ethyl-idene]hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
(E)-Methyl N'-(2-furylmethyl-ene)-hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
(E)-Methyl N'-(3-hy-droxy-benzyl-idene)hydrazinecarboxyl-ate dihydrate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
(E)-Methyl N'-[1-(4-methyl-phen-yl)ethyl-idene]hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
(E)-Methyl N'-(3,4,5-trimethoxy-benzyl-idene)hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
Ethyl (E)-2-(2-furyl-idene)hydrazine-carboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
Similarity analysis, synthesis, and bioassay of antibacterial cyclic peptidomimetics. Beilstein J Org Chem (2012) 0.75
(E)-Ethyl N'-[1-(2-hydroxy-phen-yl)ethyl-idene]hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
(E)-Methyl N'-(3,4-dimethoxy-benzyl-idene)hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
(E)-Methyl N'-(4-bromo-benzyl-idene)-hydrazinecarboxyl-ate at 123 K. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
(E)-Methyl N'-[1-(2-hydroxy-phen-yl)ethyl-idene]hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
5-((Meth-oxy-imino)-{2-[(2-methyl-phen-oxy)meth-yl]phen-yl}meth-yl)-N-phenyl-1,3,4-oxa-diazol-2-amine. Acta Crystallogr Sect E Struct Rep Online (2014) 0.75
Continuous-flow synthesis of highly functionalized imidazo-oxadiazoles facilitated by microfluidic extraction. Beilstein J Org Chem (2017) 0.75
(E)-Methyl N'-(2-hydr-oxy-3-methoxy-benzyl-idene)hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
(E)-Methyl 3-(3,5-dibromo-2-hy-droxy-benzyl-idene)carbazate. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75
(E)-Methyl N'-(2-hydroxy-benzyl-idene)-hydrazinecarboxyl-ate at 123 K. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
Methyl (E)-N'-[1-(2,4-dihydroxy-phen-yl)ethyl-idene]hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
(E)-Ethyl N'-(3-hy-droxy-benzyl-idene)hydrazinecarboxyl-ate dihydrate. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Methyl N'-[(E)-2-methoxy-benzyl-idene]-hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
(E)-Methyl N'-[1-(4-hydroxy-phen-yl)ethyl-idene]hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
(E)-Ethyl N'-(3,4-dimethoxy-benzyl-idene)hydrazinecarboxyl-ate monohydrate. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
Synthetic studies toward aryl-(4-aryl-4H-[1,2,4]triazole-3-yl)-amine from 1,3-diarylthiourea as urea mimetics. J Org Chem (2005) 0.75
(E)-Methyl N'-(3-methoxy-benzyl-idene)hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2009) 0.75
(E)-Ethyl N'-(2-hydroxy-benzyl-idene)-hydrazinecarboxyl-ate. Acta Crystallogr Sect E Struct Rep Online (2008) 0.75
Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand (1982) 3.25
Increased cerebrospinal fluid levels of endorphins after electro-acupuncture. Acta Physiol Scand (1977) 3.15
Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev (2001) 3.00
Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J Biol Chem (1996) 2.93
Immunohistochemical studies using antibodies to leucine-enkephalin: initial observations on the nervous system of the rat. Neuroscience (1976) 2.56
A molecular model of Alzheimer amyloid beta-peptide fibril formation. J Biol Chem (1999) 2.12
Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P. Proc Natl Acad Sci U S A (1977) 2.11
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
Stereospecific interaction between narcotic analgesics and a synaptic plasm a membrane fraction of rat cerebral cortex. Acta Pharmacol Toxicol (Copenh) (1973) 2.03
Enkephalin-like immunoreactivity in gland cells and nerve terminals of the adrenal medulla. Neuroscience (1978) 2.01
Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci U S A (1982) 1.95
Neurochemical basis of acupuncture analgesia. Annu Rev Pharmacol Toxicol (1982) 1.91
Effect of low- and high-frequency TENS on Met-enkephalin-Arg-Phe and dynorphin A immunoreactivity in human lumbar CSF. Pain (1991) 1.79
p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc Natl Acad Sci U S A (1994) 1.74
High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett (1983) 1.68
Characteristics of the "receptor" for narcotic analgesics in synaptic plasma membrane fraction from rat brain. Acta Pharmacol Toxicol (Copenh) (1973) 1.56
Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain. Neuron (1995) 1.56
Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm Res (1997) 1.44
Controlling amyloid beta-peptide fibril formation with protease-stable ligands. J Biol Chem (1997) 1.43
The receptor for the orexigenic peptide melanin-concentrating hormone is a G-protein-coupled receptor. Nat Cell Biol (1999) 1.43
Peptide neurons in the vagus, splanchnic and sciatic nerves. Acta Physiol Scand (1978) 1.42
Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry (2010) 1.41
Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience (1984) 1.41
Malignant and benign human mammary disease: estrogen binding in relation to clinical data. Cancer (1974) 1.39
p53 binds single-stranded DNA ends through the C-terminal domain and internal DNA segments via the middle domain. Nucleic Acids Res (1995) 1.33
Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via GalR1 and GalR2 receptors. Proc Natl Acad Sci U S A (2001) 1.29
Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Mol Psychiatry (2008) 1.28
The binding of estradiol-17beta to human breast cancers and other tissues in vitro. Cancer Res (1970) 1.27
Enkephalin immunoreactive nerve fibres and cell bodies in sympathetic ganglia of the guinea-pig and rat. Neuroscience (1979) 1.26
Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur J Neurosci (1997) 1.26
Enkephalin- and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma. Proc Natl Acad Sci U S A (1979) 1.26
Amyloid beta-peptide polymerization studied using fluorescence correlation spectroscopy. Chem Biol (1999) 1.26
Enkephalin-like immunoreactivity in nerve terminals in sympathetic ganglia and adrenal medulla and in adrenal medullary gland cells. Acta Physiol Scand (1978) 1.26
Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone. J Pharmacol Exp Ther (2003) 1.25
Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain (1988) 1.25
A systematic genomewide linkage study in 353 sib pairs with schizophrenia. Am J Hum Genet (2003) 1.24
Ibotenic acid-induced neuronal degeneration: a morphological and neurochemical study. Exp Brain Res (1979) 1.22
Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists. J Med Chem (2001) 1.21
NADPH-diaphorase: a selective histochemical marker for striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities. J Comp Neurol (1983) 1.20
Endogenous peptides and analgesia. Annu Rev Pharmacol Toxicol (1978) 1.19
Calcitonin gene-related peptide is a potent inhibitor of substance P degradation. Eur J Pharmacol (1985) 1.19
Substance P-, VIP-, and enkephalin-like immunoreactivity in the human vagus nerve. Gastroenterology (1979) 1.19
Correlation of drug absorption with molecular surface properties. J Pharm Sci (1996) 1.17
The Alzheimer A beta peptide develops protease resistance in association with its polymerization into fibrils. J Biol Chem (1994) 1.17
Somatostatin and ACTH are peptides with partial antagonist-like selectivity for opiate receptors. Eur J Pharmacol (1976) 1.13
Origin of peptide-containing fibers in the inferior mesenteric ganglion of the guinea-pig: immunohistochemical studies with antisera to substance P, enkephalin, vasoactive intestinal polypeptide, cholecystokinin and bombesin. Neuroscience (1983) 1.13
New diarylmethylpiperazines as potent and selective nonpeptidic delta opioid receptor agonists with increased In vitro metabolic stability. J Med Chem (2000) 1.11
Search for an endogenous ligand for the opiate receptor. Acta Physiol Scand (1975) 1.11
NF-kappa B-like factors in the murine brain. Developmentally-regulated and tissue-specific expression. Brain Res Mol Brain Res (1993) 1.10
Specific uptake of oestrogens by the mouse uterus in vitro. Acta Endocrinol (Copenh) (1966) 1.10
Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity. Proc Natl Acad Sci U S A (1983) 1.09
Experimental and computational screening models for the prediction of intestinal drug absorption. J Med Chem (2001) 1.08
Immunocytochemical identification of polypeptide YY (PYY) cells in the human gastrointestinal tract. Histochemistry (1983) 1.08
Neuropeptide Y (NPY)- and FMRFamide neuropeptide-like immunoreactivities in catecholamine neurons of the rat medulla oblongata. Acta Physiol Scand (1983) 1.08
Enkephalin and beta-endorphin as mediators of electro-acupuncture analgesia in rabbits: an antiserum microinjection study. Adv Biochem Psychopharmacol (1982) 1.07
Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues. J Auton Nerv Syst (1988) 1.07
Evidence for differential localization of noradrenaline and neuropeptide Y in neuronal storage vesicles isolated from rat vas deferens. J Neurosci (1985) 1.07
Immunohistochemical studies on the effect of capsaicin on spinal and medullary peptide and monoamine neurons using antisera to substance P, gastrin/CCK, somatostatin, VIP, enkephalin, neurotensin and 5-hydroxytryptamine. J Neurocytol (1981) 1.07
Peptide neurons in peripheral tissues including the urinary tract: immunohistochemical studies. Acta Pharmacol Toxicol (Copenh) (1978) 1.06
Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus. Neuroscience (1988) 1.05
Letter: A rapid assay of affinity for the narcotic receptor in rat brain: application to methadone analogues. Acta Pharmacol Toxicol (Copenh) (1974) 1.04
Anti-oestrogens and breast cancer. Eur J Cancer (1971) 1.04
Comparative immunohistochemical and biochemical analysis of pancreatic polypeptide-like peptides with special reference to presence of neuropeptide Y in central and peripheral neurons. J Neurosci (1984) 1.03
Peptides in the cat carotid body (glomus caroticum): VIP-, enkephalin-, and substance P-like immunoreactivity. Acta Physiol Scand (1979) 1.03
N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor. J Med Chem (1999) 1.02
Neuropeptide Y, enkephalin and noradrenaline coexist in sympathetic neurons innervating the bovine spleen. Biochemical and immunohistochemical evidence. Cell Tissue Res (1986) 1.01
Effect of peptides and amino acids on dihydromorphine binding to the opiate receptor. J Pharm Pharmacol (1975) 1.01
ACTH-like peptides and opiate receptors in the rat brain: structure-activity studies. Eur J Pharmacol (1976) 1.01
Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat. Acta Physiol Scand (1983) 1.01
Endorphin activity in childhood psychosis. Spinal fluid levels in 24 cases. Arch Gen Psychiatry (1985) 1.00
Aminergic and peptidergic pathways in the nervous system with special reference to the hypothalamus. Res Publ Assoc Res Nerv Ment Dis (1978) 1.00
Study of molecular events in cells by fluorescence correlation spectroscopy. Cell Mol Life Sci (2005) 1.00
Structure-activity relationships of anti-oestrogens with regard to interaction with 17-beta-oestradiol in the mouse uterus and vagina. Acta Endocrinol (Copenh) (1971) 1.00
Coexistence and gene expression of phenylethanolamine N-methyltransferase, tyrosine hydroxylase, and neuropeptide tyrosine in the rat and bovine adrenal gland: effects of reserpine. Proc Natl Acad Sci U S A (1988) 0.99
Neuropeptide Y inhibits cardiac adenylate cyclase through a pertussis toxin-sensitive G protein. J Biol Chem (1987) 0.99
On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis. J Neurochem (1996) 0.99
Dysregulation of dynorphins in Alzheimer disease. Neurobiol Aging (2006) 0.98
Dynorphin-immunoreactive neurons in the central nervous system of the rat. Neurosci Lett (1982) 0.98
A comparison between microwave irradiation and decapitation: basal levels of dynorphin and enkephalin and the effect of chronic morphine treatment on dynorphin peptides. Neuropeptides (1997) 0.98
Organizational principles in the peripheral sympathetic nervous system: subdivision by coexisting peptides (somatostatin-, avian pancreatic polypeptide-, and vasoactive intestinal polypeptide-like immunoreactive materials). Proc Natl Acad Sci U S A (1982) 0.98
Distribution of neuropeptide immunoreactive nerve terminals within the subnuclei of the nucleus of the tractus solitarius of the rat. J Comp Neurol (1984) 0.97
'Neuropeptide tyrosine' (NPY) is co-stored with noradrenaline in vascular but not in parenchymal sympathetic nerves of brown adipose tissue. Exp Cell Res (1986) 0.97
N,N-Diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide: a novel, exceptionally selective, potent delta opioid receptor agonist with oral bioavailability and its analogues. J Med Chem (2000) 0.96
Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. J Pharmacol Exp Ther (1999) 0.96
Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.96
Characterization of the binding of the first selective radiolabelled histamine H3-receptor antagonist, [125I]-iodophenpropit, to rat brain. Br J Pharmacol (1994) 0.96
Neuropeptide tyrosine in the rat adrenal gland--immunohistochemical and in situ hybridization studies. Neuroscience (1988) 0.96
Binding of amyloid beta-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease. FEBS Lett (1999) 0.95
Cloning and characterization of a cDNA encoding a novel subtype of rat thyrotropin-releasing hormone receptor. J Biol Chem (1998) 0.95
Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptor-mediated effect. Neuroscience (1998) 0.95
The PHI (PHI-27)/corticotropin-releasing factor/enkephalin immunoreactive hypothalamic neuron: possible morphological basis for integrated control of prolactin, corticotropin, and growth hormone secretion. Proc Natl Acad Sci U S A (1983) 0.94
Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway. Eur J Pharmacol (1982) 0.93
Endorphins in chronic pain. I. Differences in CSF endorphin levels between organic and psychogenic pain syndromes. Pain (1978) 0.93
Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides. J Pharmacol Exp Ther (1999) 0.93
Evidence for vagal enkephalinergic neural control of the feline pylorus and stomach. Gastroenterology (1980) 0.92
Opiate receptor affinity of peptides related to Leu-enkephalin. Biochem Biophys Res Commun (1976) 0.92
Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biol Psychiatry (1996) 0.92